Advertisement

Inflammation: good or bad for ADHD?

  • Rossen Donev
  • Johannes ThomeEmail author
Review Article

Abstract

Attention deficit hyperactivity disorder (ADHD) is characterised by the typical behavioural core symptoms of inattentiveness, hyperactivity and impulsiveness. ADHD is a usually chronic health conditions, mostly diagnosed in childhood, creating a significant challenge for youth, their families and professionals who treat it. This disorder requires long-term treatments, including psychotherapeutic and pharmacological interventions, which in some cases may lead to adverse effects. Understanding the mechanism by which ADHD risk factors affect the biochemical processes in the human brain and consequentially the behaviour will help to identify novel targets for the development of therapeutics with less adverse results and better efficacy including higher responder rates. Although inflammatory responses in the brain have been recognised for years as critical in neurodegeneration and behaviour in a number of neurological and psychiatric disorders, their role for the development, treatment and prevention of ADHD has been so far largely overlooked, although historically, ADHD symptoms were initially observed in patients who survived an ONJ infection, i.e. inflammation. In this review, we discuss the interrelationship between different ADHD risk factors and inflammation with respect to the triggered molecular mechanisms and the contribution they are likely to have to this disorder. This paper provides a rationale for future studies on ADHD with an intent to inspiring the development of new agents for a more efficient management of this disorder.

Keywords

ADHD Inflammation Cytokines Apoptosis Neurogenesis Neurodegeneration 

References

  1. Aerts N, De Knop K, Leysen J, Ebo D, Bridts C, Weyler J, Stevens W, De Clerck L (2010) Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (in press)Google Scholar
  2. Asghar S, Pasch M (2000) Therapeutic inhibition of the complement system. Y2K update. Front Biosci 5:E63–E81PubMedCrossRefGoogle Scholar
  3. Atkins C, Oliva AJ, Alonso O, Pearse D, Bramlett H, Dietrich W (2007) Modulation of the cAMP signaling pathway after traumatic brain injury. Exp Neurol 208:145–158PubMedCrossRefGoogle Scholar
  4. Barbacid M, Lamballe F, Pulido D, Klein R (1991) The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta 1072:115–127PubMedGoogle Scholar
  5. Barnum S (1995) Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6:132–146PubMedCrossRefGoogle Scholar
  6. Bazan N (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29:263–271PubMedCrossRefGoogle Scholar
  7. Bergamaschi A, Corsi M, Garnier M (2006) Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells. Cell Signal 18:1679–1684PubMedCrossRefGoogle Scholar
  8. Bhat N, Zhang P, Lee J, Hogan E (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633–1641PubMedGoogle Scholar
  9. Bonci A, Williams J (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796–803PubMedGoogle Scholar
  10. Bradstreet J, Smith S, Baral M, Rossignol D (2010) Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern Med Rev 15:15–32PubMedGoogle Scholar
  11. Chalon S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75:259–269PubMedCrossRefGoogle Scholar
  12. Choi S, Joe E, Kim S, Jin B (2003) Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23:5877–5886PubMedGoogle Scholar
  13. Church DF, Pryor WA (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111–126PubMedCrossRefGoogle Scholar
  14. Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151PubMedCrossRefGoogle Scholar
  15. Combs C, Karlo J, Kao S, Landreth G (2001) beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179–1188PubMedGoogle Scholar
  16. Conner A, Kissling C, Hodges E, Hünnerkopf R, Clement R, Dudley E, Freitag C, Rösler M, Retz W, Thome J (2008) Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population. Am J Med Genet B Neuropsychiatr Genet 147B:1476–1480PubMedCrossRefGoogle Scholar
  17. Conrad C, Marshall P, Talent J, Malakowsky C, Choi J, Gracy R (2000) Oxidized proteins in Alzheimer’s plasma. Biochem Biophys Res Commun 275:678–681PubMedCrossRefGoogle Scholar
  18. Costenbader KH, Karlson EW (2006) Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 15:737–745PubMedCrossRefGoogle Scholar
  19. Coti Bertrand P, O’Kusky J, Innis S (2006) Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J Nutr 136:1570–1575PubMedGoogle Scholar
  20. Crews F, Nixon K (2009) Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol 44:115–127PubMedGoogle Scholar
  21. Dai S, Zhou Y, Li W, An J, Li P, Yang N, Chen X, Xiong R, Liu P, Zhao Y, Shen H, Zhu P, Chen J (2010) Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. J Neurosci 30:5802–5810PubMedCrossRefGoogle Scholar
  22. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I (2009) S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793:1008–1022PubMedCrossRefGoogle Scholar
  23. Donev R, Kolev M, Millet B, Thome J (2009) Neuronal death in Alzheimer’s disease and therapeutic opportunities. J Cell Mol Med 13:4329–4348PubMedCrossRefGoogle Scholar
  24. Emmerling M, Watson M, Raby C, Spiegel K (2000) The role of complement in Alzheimer’s disease pathology. Biochim Biophys Acta 1502:158–171PubMedGoogle Scholar
  25. Encinas JM, Manganas L, Enikolopov G (2005) Nitric oxide and multiple sclerosis. Curr Neurol Neurosci Rep 5:232–238PubMedCrossRefGoogle Scholar
  26. Fenton W, Dickerson F, Boronow J, Hibbeln J, Knable M (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158:2071–2074PubMedCrossRefGoogle Scholar
  27. Forsberg P, Martin S, Nilsson B, Ekman P, Nilsson U, Engström L (1990) In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways. J Biol Chem 265:2941–2946PubMedGoogle Scholar
  28. Fredriksson A, Archer T (2004) Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotox Res 6:435–456PubMedCrossRefGoogle Scholar
  29. García-Nogales P, Almeida A, Bolaños J (2003) Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. J Biol Chem 278:864–874PubMedCrossRefGoogle Scholar
  30. Gershov D, Kim S, Brot N, Elkon K (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192:1353–1364PubMedCrossRefGoogle Scholar
  31. Grossfield A, Feller S, Pitman M (2006) A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc Natl Acad Sci USA 103:4888–4893PubMedCrossRefGoogle Scholar
  32. Hakobyan S, Harris C, van den Berg C, Fernandez-Alonso M, de Jorge E, de Cordoba S, Rivas G, Mangione P, Pepys M, Morgan B (2008) Complement factor H binds to denatured rather than to native pentameric C-reactive protein. J Biol Chem 283:30451–30460PubMedCrossRefGoogle Scholar
  33. Harper C (1998) The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 57:101–110PubMedCrossRefGoogle Scholar
  34. Harper C, Matsumoto I (2005) Ethanol and brain damage. Curr Opin Pharmacol 5:73–78PubMedCrossRefGoogle Scholar
  35. Hill D, D’Souza N, Lee E, Burikhanov R, Deaciuc I, de Villiers W (2002) A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26:74–82PubMedGoogle Scholar
  36. Hofmann M, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath M, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt A (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889–901PubMedCrossRefGoogle Scholar
  37. Hope B, Nagarkar D, Leonard S, Wise R (2007) Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers. J Neurosci 27:1964–1972PubMedCrossRefGoogle Scholar
  38. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann H, Waisman A, Kuhlmann C (2010) Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24:1023–1034PubMedCrossRefGoogle Scholar
  39. Jonakait G (2007) The effects of maternal inflammation on neuronal development: possible mechanisms. Int J Dev Neurosci 25:415–425PubMedCrossRefGoogle Scholar
  40. Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 53:174–180PubMedCrossRefGoogle Scholar
  41. Kaur C, Ling E (2008) Antioxidants and neuroprotection in the adult and developing central nervous system. Curr Med Chem 15:3068–3080PubMedCrossRefGoogle Scholar
  42. Kawakita E, Hashimoto M, Shido O (2006) Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 139:991–997PubMedCrossRefGoogle Scholar
  43. Kholodenko R, Kholodenko I, Sorokin V, Tolmazova A, Sazonova O, Buzdin A (2007) Anti-apoptotic effect of retinoic acid on retinal progenitor cells mediated by a protein kinase A-dependent mechanism. Cell Res 17:151–162PubMedCrossRefGoogle Scholar
  44. King V, Huang W, Dyall S, Curran O, Priestley J, Michael-Titus A (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26:4672–4680PubMedCrossRefGoogle Scholar
  45. Kolev M, Ruseva M, Harris C, Morgan B, Donev R (2009) Implication of complement system and its regulators in Alzheimer’s disease. Curr Neuropharmacol 7:1–8PubMedCrossRefGoogle Scholar
  46. Kolev M, Tediose T, Sivasankar B, Harris C, Thome J, Morgan B, Donev R (2010) Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration. Pharmacogenomics J 10:12–19PubMedCrossRefGoogle Scholar
  47. Kostrzewa R, Kostrzewa J, Kostrzewa R, Nowak P, Brus R (2008) Pharmacological models of ADHD. J Neural Transm 115:287–298PubMedCrossRefGoogle Scholar
  48. Lagace D, Noonan M, Eisch A (2007) Hippocampal neurogenesis: a matter of survival. Am J Psychiatry 164:205PubMedCrossRefGoogle Scholar
  49. Lasky-Su J, Neale B, Franke B, Anney R, Zhou K, Maller J, Vasquez A, Chen W, Asherson P, Buitelaar J, Banaschewski T, Ebstein R, Gill M, Miranda A, Mulas F, Oades R, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen H, Taylor E, Daly M, Laird N, Lange C, Faraone S (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147B:1345–1354PubMedCrossRefGoogle Scholar
  50. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Devière J (1995) Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology 22:1436–1439PubMedCrossRefGoogle Scholar
  51. Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Devière J (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49:646–657PubMedCrossRefGoogle Scholar
  52. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154–1162PubMedCrossRefGoogle Scholar
  53. Linnet K, Dalsgaard S, Obel C, Wisborg K, Henriksen T, Rodriguez A, Kotimaa A, Moilanen I, Thomsen P, Olsen J, Jarvelin M (2003) Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 160:1028–1040PubMedCrossRefGoogle Scholar
  54. Liu JS, Zhao ML, Brosnan CF, Lee SC (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158:2057–2066PubMedGoogle Scholar
  55. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler B, De Caterina R (2006) The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 103:15184–15189PubMedCrossRefGoogle Scholar
  56. McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok K, Porteous L, Prince E, Sonuga-Barke E, Warner J, Stevenson J (2007) Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370:1560–1567PubMedCrossRefGoogle Scholar
  57. McClain C, Cohen D (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349–351PubMedCrossRefGoogle Scholar
  58. McClain C, Hill D, Song Z, Chawla R, Watson W, Chen T, Barve S (2002) S-adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol 27:185–192PubMedCrossRefGoogle Scholar
  59. Melis M, Camarini R, Ungless M, Bonci A (2002) Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J Neurosci 22:2074–2082PubMedGoogle Scholar
  60. Mick E, Biederman J, Faraone S, Sayer J, Kleinman S (2002) Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 41:378–385PubMedCrossRefGoogle Scholar
  61. Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P (2004) Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 9:801–810PubMedCrossRefGoogle Scholar
  62. Miller VM, Lewis DA, Rud KS, Offord KP, Croghan IT, Hurt RD (1998) Plasma nitric oxide before and after smoking cessation with nicotine nasal spray. J Clin Pharmacol 38:22–27PubMedGoogle Scholar
  63. Min S, Moon I, Ko R, Shin H (2001) Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers. Psychopharmacology (Berl) 159:83–88CrossRefGoogle Scholar
  64. Misener V, Schachar R, Ickowicz A, Malone M, Roberts W, Tannock R, Kennedy J, Pathare T, Barr C (2004) Replication test for association of the IL-1 receptor antagonist gene, IL1RN, with attention-deficit/hyperactivity disorder. Neuropsychobiology 50:231–234PubMedCrossRefGoogle Scholar
  65. Monje M, Toda H, Palmer T (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760–1765PubMedCrossRefGoogle Scholar
  66. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M (2006) The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 19:1437–1445PubMedGoogle Scholar
  67. Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H, Yasu T, Saito M, Momomura S, Kawakami M (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 196:129–135PubMedCrossRefGoogle Scholar
  68. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M (1997) Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 79:1538–1541PubMedCrossRefGoogle Scholar
  69. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952PubMedCrossRefGoogle Scholar
  70. Osaka H, Mukherjee P, Aisen P, Pasinetti G (1999) Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 73:303–311PubMedCrossRefGoogle Scholar
  71. Paine T, Neve R, Carlezon WJ (2009) Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology 34:2143–2155PubMedCrossRefGoogle Scholar
  72. Pasinetti G (1996) Inflammatory mechanisms in neurodegeneration and Alzheimer’s disease: the role of the complement system. Neurobiol Aging 17:707–716PubMedCrossRefGoogle Scholar
  73. Qin L, He J, Hanes R, Pluzarev O, Hong J, Crews F (2008) Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 5:10PubMedCrossRefGoogle Scholar
  74. Raz R, Gabis L (2009) Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev Med Child Neurol 51:580–592PubMedCrossRefGoogle Scholar
  75. Redford EJ, Kapoor R, Smith KJ (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120(Pt 12):2149–2157PubMedCrossRefGoogle Scholar
  76. Reif A, Rösler M, Freitag C, Schneider M, Eujen A, Kissling C, Wenzler D, Jacob C, Retz-Junginger P, Thome J, Lesch K, Retz W (2007) Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology 32:2375–2383PubMedCrossRefGoogle Scholar
  77. Reif A, Jacob C, Rujescu D, Herterich S, Lang S, Gutknecht L, Baehne C, Strobel A, Freitag C, Giegling I, Romanos M, Hartmann A, Rösler M, Renner T, Fallgatter A, Retz W, Ehlis A, Lesch K (2009) Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 66:41–50PubMedCrossRefGoogle Scholar
  78. Retz W, Reif A, Freitag C, Retz-Junginger P, Rösler M (2010) Association of a functional variant of neuronal nitric oxide synthase gene with self-reported impulsiveness, venturesomeness and empathy in male offenders. J Neural Transm 117:321–324PubMedCrossRefGoogle Scholar
  79. Rezaee F, Rellick S, Piedimonte G, Akers S, O’Leary H, Martin K, Craig M, Gibson L (2010) Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One 5:e9690PubMedCrossRefGoogle Scholar
  80. Ribasés M, Hervás A, Ramos-Quiroga J, Bosch R, Bielsa A, Gastaminza X, Fernández-Anguiano M, Nogueira M, Gómez-Barros N, Valero S, Gratacòs M, Estivill X, Casas M, Cormand B, Bayés M (2008) Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 63:935–945PubMedCrossRefGoogle Scholar
  81. Riediger N, Othman R, Suh M, Moghadasian M (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109:668–679PubMedCrossRefGoogle Scholar
  82. Romanos M, Gerlach M, Warnke A, Schmitt J (2010) Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 64:269–273PubMedCrossRefGoogle Scholar
  83. Rushforth S, Allison C, Wonnacott S, Shoaib M (2010) Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task. Neurosci Lett 471:114–118PubMedCrossRefGoogle Scholar
  84. Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez-Gallerani AS (1999) Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels. J Surg Res 82:43–47PubMedCrossRefGoogle Scholar
  85. Schlaepfer I, Clegg H, Corley R, Crowley T, Hewitt J, Hopfer C, Krauter K, Lessem J, Rhee S, Stallings M, Wehner J, Young S, Ehringer M (2007) The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition. Addict Biol 12:200–209PubMedCrossRefGoogle Scholar
  86. Schmitt J, Romanos M, Schmitt N, Meurer M, Kirch W (2009) Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 301:724–726PubMedCrossRefGoogle Scholar
  87. Schmitt J, Apfelbacher C, Chen C, Romanos M, Sausenthaler S, Koletzko S, Bauer C, Hoffmann U, Krämer U, Berdel D, von Berg A, Wichmann H, Heinrich J, Group GINIpS (2010) Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 125:404–410PubMedCrossRefGoogle Scholar
  88. Segman R, Meltzer A, Gross-Tsur V, Kosov A, Frisch A, Inbar E, Darvasi A, Levy S, Goltser T, Weizman A, Galili-Weisstub E (2002) Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatry 7:72–74PubMedCrossRefGoogle Scholar
  89. Sen J, Belli A (2007) S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 85:1373–1380PubMedCrossRefGoogle Scholar
  90. Sharp S, McQuillin A, Gurling H (2009) Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 57:590–600PubMedCrossRefGoogle Scholar
  91. Shinawi M, Liu P, Kang S, Shen J, Belmont J, Scott D, Probst F, Craigen W, Graham B, Pursley A, Clark G, Lee J, Proud M, Stocco A, Rodriguez D, Kozel B, Sparagana S, Roeder E, McGrew S, Kurczynski T, Allison L, Amato S, Savage S, Patel A, Stankiewicz P, Beaudet A, Cheung S, Lupski J (2009) Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioral problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 47:332–341Google Scholar
  92. Shiow L, Paris K, Akana M, Cyster J, Sorensen R, Puck J (2009) Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin Immunol 131:24–30PubMedCrossRefGoogle Scholar
  93. Shohami E, Novikov M, Bass R, Yamin A, Gallily R (1994) Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab 14:615–619PubMedGoogle Scholar
  94. Silva C, Rio M, Cruz C (1985) Local immunoglobulin synthesis and blood-brain barrier assessment in subacute sclerosing panencephalitis. Eur Neurol 24:128–133PubMedCrossRefGoogle Scholar
  95. Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470–476PubMedCrossRefGoogle Scholar
  96. Smith M, Moylan J, Smith J, Li W, Reid M (2007) IFN-gamma does not mimic the catabolic effects of TNF-alpha. Am J Physiol Cell Physiol 293:C1947–C1952PubMedCrossRefGoogle Scholar
  97. Spector R (1988) Fatty-acid transport through the blood-brain barrier. J Neurochem 50:639–643PubMedCrossRefGoogle Scholar
  98. Stillwell W, Shaikh S, Zerouga M, Siddiqui R, Wassall S (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 45:559–579PubMedCrossRefGoogle Scholar
  99. Tai C, Chen C, Lee H, Wang Y, Li T, Mersamm H, Ding S, Wang P (2009) Docosahexaenoic acid enhances hepatic serum amyloid A expression via protein kinase A-dependent mechanism. J Biol Chem 284:32239–32247PubMedCrossRefGoogle Scholar
  100. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42:177–185PubMedCrossRefGoogle Scholar
  101. Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, Rutter M, Harold G (2009) Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry 66:722–727PubMedCrossRefGoogle Scholar
  102. Tikka T, Fiebich B, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580–2588PubMedGoogle Scholar
  103. Toga A, Thompson P, Sowell E (2006) Mapping brain maturation. Trends Neurosci 29:148–159PubMedCrossRefGoogle Scholar
  104. Vincent S (2010) Nitric oxide neurons and neurotransmission. Prog Neurobiol 90:246–255PubMedCrossRefGoogle Scholar
  105. Wan J, Fu A, Ip F, Ng H, Hugon J, Page G, Wang J, Lai K, Wu Z, Ip N (2010) Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer’s disease. J Neurosci 30:6873–6881PubMedCrossRefGoogle Scholar
  106. Wang H, Zakhari S, Jung M (2010) Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development. World J Gastroenterol 16:1304–1313PubMedCrossRefGoogle Scholar
  107. Yan S, Ramasamy R, Naka Y, Schmidt A (2003) Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93:1159–1169PubMedCrossRefGoogle Scholar
  108. Yan T, McQuillin A, Thapar A, Asherson P, Hunt S, Stanford S, Gurling H (2010) NK1 (TACR1) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHD. J Psychopharmacol 24:27–38PubMedCrossRefGoogle Scholar
  109. Zhou JF, Yan XF, Guo FZ, Sun NY, Qian ZJ, Ding DY (2000) Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed Environ Sci 13:44–55PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Academic Unit of Psychiatry, The School of MedicineUniversity of Wales SwanseaSwanseaUK

Personalised recommendations